{"id":"W4393204492","doi":"10.1016/j.jtocrr.2024.100669","title":"Characteristics of Long-Term Survivors With EGFR-Mutant Metastatic NSCLC","year":2024,"lang":"en","type":"article","venue":"JTO Clinical and Research Reports","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"ca_institutions":"Princess Margaret Cancer Centre","funders":"Daiichi Sankyo Europe; Gilead Sciences; National Cancer Institute; Canadian Cancer Society Research Institute; Canadian Institutes of Health Research; Sanofi Genzyme; AstraZeneca Korea; EMD Serono; Genentech; Daiichi-Sankyo; G1 Therapeutics; BeiGene; Mirati Therapeutics; AstraZeneca; Novocure; Regeneron Pharmaceuticals; Sanofi; Amgen; American Association for Cancer Research; Eli Lilly and Company; Bristol-Myers Squibb; Seagen; LUNGevity Foundation; Pfizer","keywords":"Osimertinib; Oncology; Medicine; Retrospective cohort study; Cohort; Internal medicine; Mutant; Term (time); Cancer; Epidermal growth factor receptor; Biology; Genetics; Gene; Erlotinib","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002833204,0.00009779025,0.0001871141,0.0004150168,0.0002479607,0.0003414752,0.0001755436,0.0002117727,0.001330631],"category_scores_gemma":[0.001046894,0.00006773975,0.0002166264,0.0005783227,0.0001683629,0.0003513729,0.0002425606,0.0001957682,0.0001262103],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001964604,"about_ca_system_score_gemma":0.0002569572,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002025513,"about_ca_topic_score_gemma":0.003137456,"domain_scores_codex":[0.9998487,0.00002112967,0.00002575067,0.00003493215,0.00002960972,0.00003986924],"domain_scores_gemma":[0.9989364,0.0001224272,0.0005824596,0.0000351616,0.00007882531,0.0002447584],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.00002097048,0.000005155993,0.999315,0.000003144326,0.000008404443,0.00005788866,0.00001487105,0.00002144022,0.00006836568,0.000005407497,0.00003320666,0.0004461943],"study_design_scores_gemma":[0.000001099792,0.00006298395,0.9992018,0.000004420885,0.000007160007,0.0004187569,0.00009814811,0.00005163747,0.00003067132,0.00001250946,0.0001089758,0.000001832313],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9991722,0.0001609028,0.00003551314,0.00002245057,0.000002135555,0.000003357079,0.0004166939,0.000002104625,0.0001846315],"genre_scores_gemma":[0.9994055,0.00006302858,0.00001980487,0.00001158113,0.000004794191,0.000003994435,0.0004284182,4.528906e-7,0.00006247013],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002025513,"threshold_uncertainty_score":0.004451454,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1094563096629582,"score_gpt":0.5031910424772752,"score_spread":0.3937347328143169,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}